MedPath

HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms

Not Applicable
Completed
Conditions
Childhood Trauma
Major Depressive Disorder
Interventions
Other: stress
Registration Number
NCT02398877
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

This study evaluates the association between early trauma, depression and metabolic symptoms.

Detailed Description

Early traumatic stress is associated with alterations of the hypothalamic-pituitary-adrenal axis (HPA-axis) indicated by an increased response to stress, a diminished negative feedback and alterations in expression of glucocorticoid receptors. Patients with a history of childhood trauma are more likely to develop metabolic disorders such as diabetes mellitus type 2 or metabolic syndrome.

The investigators will examine participants with and without early life stress and with and without major depression. The investigators assume that traumatized study participants (1) show an increased endocrine stress reaction to psychosocial stress, (2) display an altered sensitivity of GR, and (3) therefore suffer from an adverse cardiovascular risk profile in comparison to not-traumatized participants.

The investigators study will increase current knowledge on possible sequel of early traumatic stress. The results will lead to a more comprehensive understanding of stress-related eating behaviour and its implications.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
140
Inclusion Criteria
  • diagnosis of MDD and/or experience of early trauma
Exclusion Criteria
  • severe illness,
  • control group: no diagnosis of MDD and experience of early trauma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Depression without early traumastressstress
Depression with early traumastressstress
Healthy with early traumastressstress
Healthy without early traumastressstress
Primary Outcome Measures
NameTimeMethod
Endocrine response to stress (salivary cortisol)2 hours

salivary cortisol

glucose to oral glucose tolerance test (plasma insulin)2 hours

plasma glucose

insulin to oral glucose tolerance test (plasma insulin)2 hours

plasma insulin

cortisol to corticotropin releasing factor (salivary cortisol)3 hours

salivary cortisol

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Charite University

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath